Metabolism of Fibric Acid Derivatives
- 1 January 1998
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 34 (5) , 419-420
- https://doi.org/10.2165/00003088-199834050-00006
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)Clinical Pharmacokinetics, 1998
- Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1997
- Human P450 metabolism of warfarinPharmacology & Therapeutics, 1997
- EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1Transplantation, 1996
- Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acidClinical Pharmacology & Therapeutics, 1996
- In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin*Clinical Pharmacology & Therapeutics, 1995
- Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent ItraconazoleNew England Journal of Medicine, 1995
- Drug interactions with fibric acidsPharmacology & Therapeutics, 1994